Anand V. Kulkarni

Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

Juan Pablo Arab, Luis Antonio Díaz, Natalia Baeza et al. · Journal of Hepatology · 2021 · 141 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome

Cumali Efe, Anand V. Kulkarni, Benedetta Terziroli Beretta‐Piccoli et al. · Hepatology · 2022 · 116 citations · Full text

Medicine, Immunology, Infectious Diseases +17

Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes

Luis Antonio Díaz, Eduardo Fuentes–López, Francisco Idalsoaga et al. · Journal of Hepatology · 2023 · 97 citations · Full text

Public Affairs, Health Policy, Cancer Epidemiology +15

The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease

Cheng Han Ng, Kai En Chan, Yip Han Chin et al. · Clinical and Molecular Hepatology · 2022 · 83 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Impact of COVID-19 on liver transplant recipients–A systematic review and meta-analysis

Anand V. Kulkarni, Harsh Vardhan Tevethia, Madhumita Premkumar et al. · EClinicalMedicine · 2021 · 76 citations · Full text

Medicine, Immunology, Infectious Diseases +17